Related Experiment Video
Updated: Aug 8, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
CHOROIDAL VASCULARITY INDEX, RETINAL VASCULARITY, AND HEMOGLOBIN LEVELS IN PEDIATRIC SICKLE CELL MACULOPATHY
Celine Chaaya1,2, Sandra Hoyek1,2, Francisco Altamirano2
1Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Pediatric sickle cell disease (SCD) patients show reduced choroidal vascularity index (CVI), linked to lower retinal vessel density and hemoglobin levels, suggesting choroidal ischemia in sickle cell maculopathy.
Area of Science:
- Ophthalmology
- Hematology
- Pediatrics
Background:
- Sickle cell disease (SCD) can affect the eyes, potentially leading to complications like sickle cell maculopathy.
- The choroidal vascularity index (CVI) is a measure of vascularity in the choroid, a layer of blood vessels in the eye.
- Understanding ocular changes in pediatric SCD is crucial for early detection and management.
Purpose of the Study:
- To evaluate the choroidal vascularity index (CVI) in children with sickle cell disease (SCD).
- To assess the association between CVI, retinal thickness, and retinal vasculature in pediatric SCD patients.
- To compare CVI in pediatric SCD patients with healthy controls.
Main Methods:
- Retrospective case series comparing pediatric SCD patients with age-matched healthy controls.
- Automated machine learning algorithm used for Choroidal Vascularity Index (CVI) measurement.
- Retinal assessments included total retinal thickness and vessel density (VD).
Main Results:
- Pediatric SCD patients had a significantly lower mean CVI (54%) compared to healthy controls (69%).
- Lower CVI in SCD eyes was associated with reduced inferotemporal retinal vessel density (VD) and increased retinal thickness in specific macular areas.
- Eyes with lower CVI also showed significantly lower mean hemoglobin (Hgb) levels.
Conclusions:
- A decreased CVI in pediatric SCD patients suggests potential choroidal ischemia contributing to sickle cell maculopathy.
- CVI may serve as a valuable biomarker for assessing systemic disease activity and ocular involvement in pediatric SCD.
- Further research can explore CVI's role in monitoring disease progression and treatment efficacy.
More Related Videos
07:18Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
Published on: February 18, 2022
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Imaging Studies VII: Vascular Imaging
Diabetic Retinopathy